HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.34

Change

+0.01 (+0.11)%

Market Cap

N/A

Volume

350.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.29 (-1.05%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.03 (+0.06%)

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

+0.35 (+1.97%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.04 (-0.06%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

-0.92 (-2.24%)

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.45%)

CAD 3.78B
CEF-U:CA Sprott Physical Gold and Silve..

+0.32 (+1.47%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.14 (+0.63%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.07 (+0.33%)

CAD 2.52B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.37% 66% D+ 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.37% 65% D 59% D-
Trailing 12 Months  
Capital Gain 7.85% 47% F 51% F
Dividend Return 0.67% 30% F 12% F
Total Return 8.52% 48% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.80% 60% D- 50% F
Dividend Return 1.86% 60% D- 45% F
Total Return 0.06% 53% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 4.15% 79% B- 91% A-
Risk Adjusted Return 44.96% 78% C+ 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike